Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Simultaneous multifunctional transcriptome engineering by CRISPR RNA scaffold. | Nucleic Acids Res | 2023 | 37395412 | PubTator, text mining | PubMed |
| Sex Difference in Spinal Muscular Atrophy Patients - are Males More Vulnerable? | J Neuromuscul Dis | 2023 | 37393514 | PubTator, text mining | PubMed |
| DEVOTE Study Exploring Higher Dose of Nusinersen in Spinal Muscular Atrophy: Study Design and Part A Results. | J Neuromuscul Dis | 2023 | 37393513 | PubTator, text mining | PubMed |
| A multilocus approach for accurate variant calling in low-copy repeats using whole-genome sequencing. | Bioinformatics | 2023 | 37387146 | PubTator, text mining | PubMed |
| A high-throughput cigarette smoke-treated bronchosphere model for disease-relevant phenotypic compound screening. | PLoS One | 2023 | 37384771 | PubTator, text mining | PubMed |
| Expanding the Availability of Onasemnogene Abeparvovec to Older Patients: The Evolving Treatment Landscape for Spinal Muscular Atrophy. | Pharmaceutics | 2023 | 37376212 | PubTator, text mining | PubMed |
| A Possible Case of Centronuclear Myopathy: A Case Report. | Medicina (Kaunas) | 2023 | 37374315 | PubTator, text mining | PubMed |
| Serum Neurofilaments in Motor Neuron Disease and Their Utility in Differentiating ALS, PMA and PLS. | Life (Basel) | 2023 | 37374084 | PubTator, text mining | PubMed |
| Spinal Cord Organoids to Study Motor Neuron Development and Disease. | Life (Basel) | 2023 | 37374039 | PubTator, text mining | PubMed |
| Determination of the Duplicated CYP2D6 Allele Using Real-Time PCR Signal: An Alternative Approach. | J Pers Med | 2023 | 37373874 | PubTator, text mining | PubMed |
| In Vitro Modeling as a Tool for Testing Therapeutics for Spinal Muscular Atrophy and IGHMBP2-Related Disorders. | Biology (Basel) | 2023 | 37372153 | PubTator, text mining | PubMed |
| Early Development of Spinal Deformities in Children Severely Affected with Spinal Muscular Atrophy after Gene Therapy with Onasemnogene Abeparvovec-Preliminary Results. | Children (Basel) | 2023 | 37371230 | PubTator, text mining | PubMed |
| Evaluation of the orally bioavailable 4-phenylbutyrate-tethered trichostatin A analogue AR42 in models of spinal muscular atrophy. | Sci Rep | 2023 | 37365234 | PubTator, text mining | PubMed |
| Comparison of pharmacogenomic information for drug approvals provided by the national regulatory agencies in Korea, Europe, Japan, and the United States. | Front Pharmacol | 2023 | 37361213 | PubTator, text mining | PubMed |
| Effects of the COVID-19 Pandemic on SMA Screening and Care: Physician and Community Insights. | Neurol Ther | 2023 | 37347432 | PubTator, text mining | PubMed |
| Analysis of Structural Variants Previously Associated With ALS in Europeans Highlights Genomic Architectural Differences in Africans. | Neurol Genet | 2023 | 37346932 | PubTator, text mining | PubMed |
| Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma. | Cancers (Basel) | 2023 | 37345159 | PubTator, text mining | PubMed |
| The Frequency of SMN1, SMN2 Copy Numbers in 246 Turkish Cases Analyzed with MLPA Method. | Glob Med Genet | 2023 | 37332684 | PubTator, text mining | PubMed |
| The potential role and mechanism of circRNA/miRNA axis in cholesterol synthesis. | Int J Biol Sci | 2023 | 37324939 | PubTator, text mining | PubMed |
| Ethical challenges and opportunities in the development and approval of novel therapeutics for rare diseases. | J Med Access | 2023 | 37323852 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=27